Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has caused significant morbidity and mortality worldwide. Though previous coronaviruses have caused substantial epidemics in recent years, effective therapies remained limited at the start of the Coronavirus disease 19 (COVID-19) pandemic....
Main Authors: | Divya Narayanan, Tanyalak Parimon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/14/7702 |
Similar Items
-
Vasculitis and COVID-19: what do we have to know?
by: Antonio Tamburello, et al.
Published: (2020-12-01) -
Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
by: Chuan-bin Sun, et al.
Published: (2020-04-01) -
Animal Coronaviruses and SARS-COV-2 in Animals, What Do We Actually Know?
by: Paolo Bonilauri, et al.
Published: (2021-02-01) -
SARS-CoV-2 and the Brain: What Do We Know about the Causality of ‘Cognitive COVID?
by: Hashir Ali Awan, et al.
Published: (2021-08-01) -
Erythema Multiforme and COVID-19: What Do We Know?
by: Luigi Bennardo, et al.
Published: (2021-08-01)